EMEduardo Carvalho Miranda

Eduardo Carvalho Miranda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eduardo Carvalho Miranda has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of Frameless Stereotactic-Guided Brain Lesion Biopsies in a Referral Hospital of the Brazilian Public Health System

    by Franklin Bernardes Faraj de Lima, Hian Penna Gavazza Figueiredo, Bárbara Caroline Dias Faria, João Pedro Santos Albuquerque, Júlio César de Almeida, Mauricio Buzelin Nunes, Eduardo Carvalho Miranda, Aline Pimentel Amaro, Tiago Ribeiro Ferreira, Marcos Antônio Dellaretti Filho

    Frameless biopsy (FLB) is a procedure to obtain samples of brain lesions. The available studies indicate that its rate is lower when compared to frame-based stereotaxic procedures. To demonstrate FLB's accuracy for intracranial lesions and to evaluate the noncontrast computed tomography (NCCT) in relation to the biopsied target in the immediate postoperative period. Also, to compare efficacy and complication data with frame-based biopsies. A total of 50 patients who underwent FLB at Santa Casa de Misericórdia de Belo Horizonte (SCMBH) between 2022 and 2023 were included. Evaluation of postoperative NCCT scans was performed by three independent neuroradiologists. The complications rate was 4 (8%), including 1 case of permanent neurological deficit, 2 cases of symptomatic hemorrhage with transient motor deficit, and 1 case of cerebral edema progressing to death. Furthermore, 46 (92%) patients were diagnosed, and the diagnosis rate correlated with lesion diameter and number of fragments (p = 0.02 and 0.03, respectively). Radiological evaluation of postoperative NCCT scans revealed a concordance rate of 84 and 86% between the planned biopsy target and the real site of tissue collection. There was a high level of agreement between the neuroradiologists' analyses (kappa: 0.76–0.84). Compared to the frame-based group, the analyses yielded significant correlation between biopsy technique and gender (p = 0.01). The present study demonstrates that FLB technique is effective and safe for biopsies of intracranial lesions, presenting similar efficacy and safety to stereotactic biopsy. Additionally, the NCCT proved to be a good method to assess biopsy agreement.

  • Open Access

    Reply

    by Leonardo Furtado Freitas, Eduardo Carvalho Miranda, Thelma Ribeiro Noce, Aline Pimentel Amaro, Márcio Luís Duarte

    The pathogenicity of variant c.597dup in SLC19A3 and treatability of its phenotype remain unconfirmed Dear Editor, Initially, we would like to thank Josef Finsterer and Fulvio Scorza for their comments and for the opportunity to discuss this case report.[1] There is a typing error, and the correct name of the gene in question is SLC19A3, whose inheritance is indeed autosomal recessive. Genetic exome analysis showed 2 different mutations in the SLC19A3 gene. A pathogenic variant c.597dup p.(His200Serfs*25) and a variant of uncertain significance (VUS) c.488C > T p.(Ser163Phe). These mutations are on different alleles (compound heterozygosity), which would function as homozygosity. This would explain the disease and the variant of uncertain significance should be reclassified as probably pathogenic. So far, therefore, we do not doubt the diagnosis, after a multidisciplinary discussion with a pediatric neurologist and geneticist. The patient in question did not die, and showed a slight clinical improvement with treatment, despite having sequelae and a very poor prognosis due to the parenchymal changes in the brain, even with high-dose treatment. He is currently taking 500 mg of thiamine and 80 mg of biotin in the morning and 300 mg of thiamine and 40 mg of biotin in the evening. The parents' genetic tests have been requested but are not yet available at the time of this letter. We would like to thank you again for the comments and the possibility of corrections and clarifications. Received: 08 March 2024 Accepted: 13 March 2024 Article published online: 12 April 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

  • Open Access

    SCL19A3 gene mutation with Leigh-like phenotype presentation: a potentially treatable disease

    by Leonardo Furtado Freitas, Eduardo Carvalho Miranda, Thelma Ribeiro Noce, Aline Pimentel Amaro, Márcio Luís Duarte

    A two-month-old boy presented with breastfeeding difficulty, hypoactivity, hyporeactivity, and seizures. Neuroimaging showed multiple areas of cytotoxic and vasogenic edema in the midbrain, cerebellum, basal ganglia, and brain hemispheres, with lactate peak ([Figure 1]). Exome sequencing revealed a heterozygous mutation c.597dup (p.His200Serfs*25) in the SCL19A3 gene. The SCL19A3 gene encodes thiamine transporter-2. Mutations can result in thiamine metabolism dysfunction syndrome-2, and they can present as early as infantile Leigh-like syndrome,[1] a potentially treatable disease. This patient was submitted to thiamine and biotin replacement, but his evolution confirmed a poor prognosis ([Figure 2]).[2] The poor outcome warrants genetic counseling for the families. LFF: conceptualization, formal analysis, investigation, validation, visualization, writing of the original draft, and writing – review and editing; ECM: formal analysis, investigation, visualization, and writing – review & editing; TRN: formal analysis, funding acquisition, supervision, validation, and visualization; APA: investigation, supervision, validation, visualization, and writing of the original draft; MLD: validation, visualization, writing of the original draft, and writing – review and editing. Received: 26 May 2023 Accepted: 24 June 2023 Article published online: 13 October 2023 © 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil


  • Tuberomammillary Fusion and Moya-Moya Vasculopathy Associated with PHACE Syndrome

    by Leonardo Furtado Freitas, Eduardo Carvalho Miranda, Aline Pimentel Amaro, Eduardo de Oliveira Narvaez, Márcio Luís Duarte

    Received: 05 June 2023 Accepted after revision: 13 September 2023 Accepted Manuscript online: 16 September 2023 © . Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Brain abscess and hereditary hemorrhagic telangiectasia

    by Leonardo Furtado Freitas, Márcio Luís Duarte, Eduardo Carvalho Miranda